Total Payments
$3,615
2024 Payments
$408.19
Companies
21
Transactions
63
Medicare Patients
3,792
Medicare Billing
$618,620
Payment Breakdown by Category
Food & Beverage$2,512 (69.5%)
Research$1,089 (30.1%)
Education$14.30 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,512 | 58 | 69.5% |
| Unspecified | $1,089 | 1 | 30.1% |
| Education | $14.30 | 4 | 0.4% |
Payments by Type
General
$2,526
62 transactions
Research
$1,089
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Circassia Pharmaceuticals Inc | $1,089 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $561.57 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $282.84 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $221.89 | 2 | $0 (2018) |
| Shire North American Group Inc | $206.17 | 2 | $0 (2019) |
| CSL Behring | $194.88 | 4 | $0 (2024) |
| Blueprint Medicines Corporation | $148.72 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $148.06 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $129.28 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $111.01 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.19 | 17 | GlaxoSmithKline, LLC. ($152.57) |
| 2023 | $586.03 | 18 | AstraZeneca Pharmaceuticals LP ($141.92) |
| 2022 | $12.50 | 1 | Bio Products Laboratory USA, Inc. ($12.50) |
| 2021 | $90.93 | 4 | kaleo, Inc. ($31.81) |
| 2019 | $243.58 | 3 | Shire North American Group Inc ($121.87) |
| 2018 | $398.54 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.80) |
| 2017 | $1,875 | 14 | Circassia Pharmaceuticals Inc ($1,089) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $36.61 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.73 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.32 | General |
| 09/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 04/16/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.22 | General |
| Category: Allergy/Immunology | ||||||
| 04/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: IMMUNOLOGY | ||||||
| 02/16/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Immunology | ||||||
| 02/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Immunology | ||||||
| 11/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Immunology | ||||||
| 09/28/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: GENETIC DISEASE | ||||||
| 08/23/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 08/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 07/12/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 06/30/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis | Circassia Pharmaceuticals Inc | $1,089 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 933 | 13,367 | $406,628 | $176,003 |
| 2022 | 11 | 899 | 12,736 | $403,285 | $167,320 |
| 2021 | 11 | 927 | 9,703 | $311,422 | $128,152 |
| 2020 | 11 | 1,033 | 14,139 | $372,669 | $147,144 |
Total Patients
3,792
Total Services
49,945
Medicare Billing
$618,620
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 98 | 4,100 | $143,500 | $53,073 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 475 | $71,250 | $46,055 | 64.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 86 | 1,524 | $44,196 | $13,910 | 31.5% |
| 95144 | Professional service for preparation and provision of single-dose vial of allergen | Office | 2023 | 26 | 944 | $20,768 | $13,817 | 66.5% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 75 | 3,300 | $34,650 | $11,098 | 32.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 65 | 1,496 | $20,196 | $10,369 | 51.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 72 | 72 | $19,800 | $7,992 | 40.4% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 58 | 959 | $25,893 | $7,269 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 107 | $11,770 | $5,379 | 45.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $2,800 | $2,033 | 72.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $3,025 | $1,824 | 60.3% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 16 | 310 | $3,720 | $1,222 | 32.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 26 | $1,820 | $1,119 | 61.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 16 | 18 | $2,250 | $605.79 | 26.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 11 | 11 | $990.00 | $235.86 | 23.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 121 | 4,820 | $168,700 | $64,162 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 293 | 480 | $73,400 | $45,689 | 62.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 87 | 1,434 | $41,586 | $12,631 | 30.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 72 | 2,988 | $31,374 | $9,783 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $21,560 | $9,670 | 44.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 59 | 1,319 | $17,825 | $9,573 | 53.7% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 73 | 1,234 | $33,318 | $8,837 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 83 | $9,290 | $4,598 | 49.5% |
| 95044 | Test for allergy using skin patch | Office | 2022 | 16 | 266 | $3,192 | $1,111 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 22 | $1,540 | $859.38 | 55.8% |
About Dr. Sunil Perera, M.D
Dr. Sunil Perera, M.D is a Allergy healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417039371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Perera, M.D has received a total of $3,615 in payments from pharmaceutical and medical device companies, with $408.19 received in 2024. These payments were reported across 63 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,512).
As a Medicare-enrolled provider, Perera has provided services to 3,792 Medicare beneficiaries, totaling 49,945 services with total Medicare billing of $618,620. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Roseville, CA
- Active Since 10/19/2006
- Last Updated 07/09/2007
- Taxonomy Code 207KA0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417039371
Products in Payments
- NUCALA (Biological) $552.65
- Hizentra (Biological) $194.88
- AYVAKIT (Drug) $148.72
- DUPIXENT (Biological) $146.88
- TEZSPIRE (Biological) $141.92
- BEVESPI AEROSPHERE (Drug) $125.60
- HYQVIA (Biological) $121.87
- UTIBRON (Drug) $111.01
- AUVI-Q (Drug) $105.38
- CUVITRU (Biological) $104.66
- ILARIS (Biological) $89.06
- CINRYZE (Drug) $84.30
- Xhance (Drug) $54.13
- Gammaplex 10% (Biological) $48.60
- TAKHZYRO (Biological) $43.40
- XOLAIR (Drug) $40.22
- ORLADEYO (Drug) $36.61
- ImmunoCAP (Device) $36.01
- Gammaplex (Drug) $30.27
- Xolair (Biological) $24.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.